Distinctive microRNA signature associated of neoplasms with the Wnt/β-catenin signaling pathway
- PMID: 24041653
- DOI: 10.1016/j.cellsig.2013.09.006
Distinctive microRNA signature associated of neoplasms with the Wnt/β-catenin signaling pathway
Abstract
As the crucial biological regulators, microRNAs that act by suppressing their target genes are involved in a variety of pathophysiological processes. It is generally accepted that microRNAs are often dysregulated in many types of neoplasm and other human diseases. In neoplasm, microRNAs may function as oncogenes or tumor suppressors. As constitutive activation of the Wnt signaling pathway is a common feature of neoplasm and contributes to its development, progression and metastasis in various cancers, numerous studies have revealed that microRNA-mediated gene regulation are interconnected with the Wnt/β-catenin signaling pathway, forming a Wnt/β-catenin-microRNA regulatory network, which is critical to successful targeting of the Wnt/β-catenin pathway for oncotherapy. In this review, we aim to accumulate recent advances on microRNAs that work in tandem with Wnt/β-catenin signaling in tumorigenesis, with particular focus on how microRNAs affect Wnt/β-catenin activity as well as how microRNAs are regulated through the Wnt/β-catenin pathway.
Keywords: APC; Adenomatous polyposis coli; CK1α; Casein kinase 1α; DKK; Dickkop; Disheveled; Dvl; EZH2; FZD; Frizzled; GSK3β; Glycogen synthase kinase 3β; HCC; Hepatocellular carcinoma; IRS; Insulin receptor substrate; LDL receptor–related protein; LEF; LRP; Lymphoid enhancer-binding factor; NLK; Nemo-like kinase; Neoplasm; Secreted frizzled-related proteins; T-cell factor; TCF; WIF; Wnt inhibitory factor; Wnt/β-catenin signaling; Wnt–microRNA regulatory network; Zeste homologue 2; miRs; microRNA; microRNAs; sFRPs.
© 2013.
Similar articles
-
Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs.J Hepatol. 2013 Nov;59(5):1107-17. doi: 10.1016/j.jhep.2013.07.001. Epub 2013 Jul 5. J Hepatol. 2013. PMID: 23835194 Review.
-
Wnt signaling pathway in rheumatoid arthritis, with special emphasis on the different roles in synovial inflammation and bone remodeling.Cell Signal. 2013 Oct;25(10):2069-78. doi: 10.1016/j.cellsig.2013.04.002. Epub 2013 Apr 17. Cell Signal. 2013. PMID: 23602936 Review.
-
MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/β-catenin signaling in breast cancer.Oncotarget. 2016 Apr 26;7(17):24076-87. doi: 10.18632/oncotarget.8119. Oncotarget. 2016. PMID: 26992223 Free PMC article.
-
Upregulated microRNA-301a in breast cancer promotes tumor metastasis by targeting PTEN and activating Wnt/β-catenin signaling.Gene. 2014 Feb 10;535(2):191-7. doi: 10.1016/j.gene.2013.11.035. Epub 2013 Dec 4. Gene. 2014. PMID: 24315818
-
Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.Cancer Res. 2010 May 15;70(10):4233-42. doi: 10.1158/0008-5472.CAN-09-3470. Epub 2010 May 4. Cancer Res. 2010. PMID: 20442281
Cited by
-
Exosomes as secondary inductive signals involved in kidney organogenesis.J Extracell Vesicles. 2018 Jan 23;7(1):1422675. doi: 10.1080/20013078.2017.1422675. eCollection 2018. J Extracell Vesicles. 2018. PMID: 29410779 Free PMC article.
-
BASI, a potent small molecular inhibitor, inhibits glioblastoma progression by targeting microRNA-mediated β-catenin signaling.CNS Neurosci Ther. 2014 Sep;20(9):830-9. doi: 10.1111/cns.12278. Epub 2014 May 9. CNS Neurosci Ther. 2014. PMID: 24810017 Free PMC article.
-
In vitro effect of microRNA-107 targeting Dkk-1 by regulation of Wnt/β-catenin signaling pathway in osteosarcoma.Medicine (Baltimore). 2017 Jul;96(27):e7245. doi: 10.1097/MD.0000000000007245. Medicine (Baltimore). 2017. PMID: 28682874 Free PMC article.
-
Biomarker-based MicroRNA Therapeutic Strategies for Hepatocellular Carcinoma.J Clin Transl Hepatol. 2014 Dec;2(4):253-8. doi: 10.14218/JCTH.2014.00020. Epub 2014 Dec 15. J Clin Transl Hepatol. 2014. PMID: 26355266 Free PMC article. Review.
-
Nimbolide, a neem limonoid inhibits Phosphatidyl Inositol-3 Kinase to activate Glycogen Synthase Kinase-3β in a hamster model of oral oncogenesis.Sci Rep. 2016 Feb 23;6:22192. doi: 10.1038/srep22192. Sci Rep. 2016. PMID: 26902162 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous